Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RLYB is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
10 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 2
37 filers reported a long position in RLYB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ADAR1 Capital Management, LLC | $14.8M | 926.4K | +4,411.1% |
| FMR LLC | $12.7M | 794.7K | +0.2% |
| VIKING GLOBAL INVESTORS LP | $8.4M | 524.3K | Unchanged |
| TPG GP A, LLC | $6.1M | 378.6K | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | $4.8M | 300.6K | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC | $3.2M | 199.9K | +27.7% |
| Nantahala Capital Management, LLC | $3M | 188.4K | -37.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | $2.8M | 172.5K | +54% |
| Almitas Capital LLC | $1.9M | 120.7K | -36.9% |
| Rangeley Capital, LLC | $1.7M | 104.9K | +248% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.